Bausch & Lomb BLCO
NYSE BLCO
$17.56 -0.23 (-1.29%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch & Lomb (BLCO) Non Operating Interest Expenses (2022 - 2026)

Bausch & Lomb's (BLCO) quarterly Non Operating Interest Expenses came in at $93.0 million in Q2 2026, down 27.34% on a YoY basis from $128.0 million in Q2 2025, and down 4.12% quarter-over-quarter from $97.0 million in Q1 2026.

Analysis

Bausch & Lomb (BLCO) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has reported Non Operating Interest Expenses for 5 consecutive years, with $93.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non Operating Interest Expenses fell 27.34% year-over-year to $93.0 million; the trailing twelve-month figure through Jun 2026 stood at $389.0 million (down 7.38% YoY), and the FY2025 full-year result was $421.0 million, up 5.51% from the prior year.
  • Non Operating Interest Expenses retreated to $93.0 million in Q2 2026 per BLCO's latest filing, from $97.0 million in the prior quarter.
  • Across five years, Non Operating Interest Expenses topped out at $128.0 million in Q2 2025 and bottomed at $20.0 million in Q1 2022.
  • Historically, Non Operating Interest Expenses has averaged $79.9 million across 5 years, with a median of $95.5 million in 2025.
  • The sharpest annual moves came in 2023 and 2026: Non Operating Interest Expenses jumped 150.0% in 2023, then slipped 27.34% in 2026.
  • Over 5 years, Non Operating Interest Expenses stood at $47.0 million in 2022, then surged by 110.64% to $99.0 million in 2023, then fell by 1.01% to $98.0 million in 2024, then changed by 0.0% to $98.0 million in 2025, then decreased by 5.1% to $93.0 million in 2026.
  • According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $93.0 million, $97.0 million, and $98.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 351.00 Mn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn -
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 186.00 Mn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 141.00 Mn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 96.00 Mn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -53.00 Mn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 15.80 Mn
10 Bausch & Lomb 6.28 Bn 5.90 Bn 867.00 Mn 93.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 93.00 Mn
Mar 31, 2026 97.00 Mn
Dec 31, 2025 98.00 Mn
Sep 30, 2025 101.00 Mn
Jun 30, 2025 128.00 Mn
Mar 31, 2025 94.00 Mn
Dec 31, 2024 98.00 Mn
Sep 30, 2024 100.00 Mn
Jun 30, 2024 102.00 Mn
Mar 31, 2024 99.00 Mn
Dec 31, 2023 99.00 Mn
Sep 30, 2023 76.00 Mn
Jun 30, 2023 58.00 Mn
Mar 31, 2023 50.00 Mn
Dec 31, 2022 47.00 Mn
Sep 30, 2022 35.00 Mn
Jun 30, 2022 44.00 Mn
Mar 31, 2022 20.00 Mn